Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SMMT - Summit Therapeutics Inc.
86.5 M
LAST VALUE
5.37%
2 YEAR CAGR
14.55%
5 YEAR CAGR
27.96%
10 YEAR CAGR